VP, Lead IP Counsel
Dr. Nancy Wilker is an innovative intellectual property attorney with over two decades of experience in IP law. At FogPharma, Dr. Wilker plays a crucial role in crafting and executing the company’s IP strategy.
Prior to joining FogPharma, Dr. Wilker held the role of IP Counsel at Biogen, where she represented multiple clinical development programs at various stages, oversaw U.S. and foreign counsel, implemented a new docketing and annuity service for the company’s entire patent portfolio, and established and managed a team that directly interfaced with the U.S. Patent Office. Before joining Biogen, Dr. Wilker was IP Counsel at Seqirus, Inc., a CSL Company, where she was responsible for overseeing the patent estate for influenza virus vaccines. Before Seqirus, Dr. Wilker was a Partner at Sunstein Kann Murphy and Timbers LLP, where she represented biotech, pharmaceutical, and medical device clients. Before that, Dr. Wilker served as Chief IP Counsel at Cell Signaling Technology, IP Counsel at PerkinElmer, Associate at Wilmer Cutler Pickering Hale and Dorr LLP and Technology Specialist at Clark and Elbing LLP.
Dr. Wilker earned a Ph.D. in immunology from Harvard University, a J.D. from Suffolk University Law School and a B.S. in biology and biochemistry from Colorado State University.